
TheraNova LLC Profile last edited on: 4/30/2018
CAGE: 4BM38
UEI: PWMHH9QT8P93
Business Identifier: Biomedical device technologies Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 12
County: San Francisco
Congr. District: 12
County: San Francisco
Public Profile
TheraNova is a sandbox incubator and capital technology developer for medical devices. With one exception, management indicate that all the ideas for technology are internally generated with all the firm's medical device entities spinning out. TheraNova, LLC, technologies have included a low frequency induction therapy, a cardiovascular anchor, a dynamic vacuum compression, and the autosterilizing implant. The company's medical device technologies also include a non-invasive endoscopic obesity therapy, an implantable shunt designed to treat chronic fluid collections, a therapeutic hypothermia technology, a non-invasive incontinence therapy for overactive bladder, and the breast implant.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
75-99Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
1742285639 | 2 | NIH | $1,438,763 | |
Project Title: A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location | ||||
2023 | 2 | NIH | $2,656,305 | |
Project Title: A Photo-based Menstrual Blood Loss Metric | ||||
2022 | 2 | NIH | $4,929,667 | |
Project Title: Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women | ||||
2022 | 2 | NIH | $2,435,852 | |
Project Title: Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder | ||||
2022 | 2 | NIH | $1,914,459 | |
Project Title: A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location |
Key People / Management
Michelle Arney
Steve Boyd
Daniel Rogers Burnett
Peter Hardigan
Michael Jaasma
Rich Kennan
Eric Lang
Carin Lindquist
Evan Luxon
Shane Magrum -- CMO
Brett D Mensh
Devyani Nanduri
Teresa Nguyen
Bryan N Nowroozi
Kenna Silliaasen
Dimitri Sokolov
Chris Timmons
Griff Tully
Nikhil Viswanathan
Mark Ziegler
Steve Boyd
Daniel Rogers Burnett
Peter Hardigan
Michael Jaasma
Rich Kennan
Eric Lang
Carin Lindquist
Evan Luxon
Shane Magrum -- CMO
Brett D Mensh
Devyani Nanduri
Teresa Nguyen
Bryan N Nowroozi
Kenna Silliaasen
Dimitri Sokolov
Chris Timmons
Griff Tully
Nikhil Viswanathan
Mark Ziegler